CIBC Private Wealth Group
WST icon

CIBC Private Wealth Group’s West Pharmaceutical WST Stock Holding History

CIBC Private Wealth Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.78M Sell
6,481
-354
-5% -$96.8K ﹤0.01% 600
2025
Q3 		$1.79M Buy
6,835
+150
+2% +$36.5K ﹤0.01% 591
2025
Q2 		$1.46M Sell
6,685
-66
-1% -$14.1K ﹤0.01% 604
2025
Q1 		$1.29M Buy
6,751
+87
+1% +$24K ﹤0.01% 609
2024
Q4 		$2.25M Sell
6,664
-112
-2% -$35.2K ﹤0.01% 546
2024
Q3 		$2.03M Buy
6,776
+20
+0.3% +$6.13K ﹤0.01% 563
2024
Q2 		$2.16M Sell
6,756
-2,475
-27% -$875K ﹤0.01% 529
2024
Q1 		$3.65M Sell
9,231
-226
-2% -$83.6K 0.01% 449
2023
Q4 		$3.33M Sell
9,457
-193
-2% -$68.3K 0.01% 437
2023
Q3 		$3.62M Buy
+9,650
New +$3.73M 0.01% 420
2022
Q3 		– Sell
-68
Closed -$21K – 1209
2022
Q2 		$21K Sell
68
-8
-11% -$2.6K ﹤0.01% 1023
2022
Q1 		$31K Buy
+76
New +$29.8K ﹤0.01% 1068
2021
Q2 		– Sell
-11,243
Closed -$3.17M – 1075
2021
Q1 		$3.17M Sell
11,243
-1,278
-10% -$366K 0.01% 461
2020
Q4 		$3.55M Sell
12,521
-2,045
-14% -$574K 0.01% 422
2020
Q3 		$4M Buy
+14,566
New +$3.85M 0.01% 380
2018
Q1 		– Sell
-16
Closed -$2K – 2084
2017
Q4 		$2K Buy
+16
New +$1.57K ﹤0.01% 1827

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

CIBC Private Wealth Group's WST Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its West Pharmaceutical (WST) stake by 5.2% in Q4 2025, selling an estimated $96.8K and leaving 6,481 shares worth $1.78M. The position accounts for ﹤0.01% of the portfolio, ranked #600.

CIBC Private Wealth Group first reported a position in WST in Q4 2017 and has held it in 16 quarters since. The position peaked at $4M in Q3 2020. 804 funds tracked by Wall St. Rank hold WST as of Q4 2025.

  • CIBC Private Wealth Group held 6,481 shares of West Pharmaceutical worth $1.78M as of Q4 2025.
  • CIBC Private Wealth Group sold 354 West Pharmaceutical shares in Q4 2025, an estimated $96.8K.
  • West Pharmaceutical made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #600 holding.
  • CIBC Private Wealth Group first reported a position in West Pharmaceutical in Q4 2017 and has held it in 16 quarters since.
  • CIBC Private Wealth Group's West Pharmaceutical position peaked at $4M in Q3 2020.
  • 804 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.